Cancer Content

Randy Carney

Max Boyd — April 14, 2026 - 2:48pm

College of Engineering • Biomedical Engineering

A Billion Daily Repairs: How Our Cells Mend Broken DNA

Andy Fell — March 23, 2026 - 10:45am

A major new discovery could inspire improved treatments for cancer and genetic diseases.

Coiled within our cells are fragile threads of DNA that contain the codes of life— determining when each of our 30 trillion cells must grow, divide, sit tight — or simply die. This arrangement is precarious. Billions of times per day, our DNA is severed by stray chemical reactions. Our cells must rebuild the broken DNA without making mistakes – or the consequences can be dire.

New Cancer Drug Could Help Cats and People

Amy M Quinton — August 28, 2025 - 8:00am

A new cancer treatment for cats could help humans too. New 51�ԹϺ�� Davis cat clinical trial using 51�ԹϺ��SF developed drug shows the disease was controlled in 35% of cats, with minimal side effects.

Simon Cherry, Ph.D.

Tristan Peery — August 14, 2025 - 5:23pm

College of Engineering, School of Medicine (Medical Imaging)

Celina Juliano, Ph.D.

Tristan Peery — May 12, 2025 - 3:51pm

College of Biological Sciences (Regenerative Medicine)

Dr. Fred Meyers

Tristan Peery — April 02, 2025 - 9:11am

School of Medicine (Cancer Treatments)

Luis Carvajal-Carmona, Ph.D.

Tristan Peery — April 02, 2025 - 9:00am

School of Medicine (Cancer Treatment)

Dr. Joseph Tuscano

Tristan Peery — March 14, 2025 - 1:23pm

School of Medicine (Cancer Therapies)

Diana Miglioretti, Ph.D.

Tristan Peery — March 14, 2025 - 1:01pm

School of Medicine (Breast Cancer Screening)

Outside-In Signaling Shows a Route Into Cancer Cells

Andy Fell — February 04, 2025 - 9:08am

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism that could be exploited for delivering other drugs.

Many malignant cancers overexpress a protein called P-cadherin, which is embedded in the cell membrane. Because cancer cells have a lot of P-cadherin sticking out of their surface, the protein has been targeted for drug development.